Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS
Gestational diabetes mellitus is a worldwide health issue in pregnancy, posing a threat to both mother and child. One of the major risk factors for the development of gestational diabetes mellitus is polycystic ovary syndrome, primarily due to the biochemical hyperandrogenism and metabolic issues, c...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1501110/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832576571815231488 |
|---|---|
| author | Paola Quaresima Samuel H. Myers Basilio Pintaudi Basilio Pintaudi Rosario D’Anna Rosario D’Anna Michele Morelli Vittorio Unfer Vittorio Unfer |
| author_facet | Paola Quaresima Samuel H. Myers Basilio Pintaudi Basilio Pintaudi Rosario D’Anna Rosario D’Anna Michele Morelli Vittorio Unfer Vittorio Unfer |
| author_sort | Paola Quaresima |
| collection | DOAJ |
| description | Gestational diabetes mellitus is a worldwide health issue in pregnancy, posing a threat to both mother and child. One of the major risk factors for the development of gestational diabetes mellitus is polycystic ovary syndrome, primarily due to the biochemical hyperandrogenism and metabolic issues, commonly observed in these patients. In recent years, the Expert Group on Inositol in Basic and Clinical Research and on PCOS (EGOI-PCOS) has sought to better understand the pathogenesis behind polycystic ovary syndrome, in order to accurately diagnose and treat patients according to their individual needs. Through the scope of polycystic ovary syndrome, this position paper examines the characteristics of both conditions, and underlying biological mechanisms, before moving on to common treatment strategies to avoid or treat gestational diabetes mellitus in women with polycystic ovary syndrome. |
| format | Article |
| id | doaj-art-be60fd8674e44d2eacb73fd63d5cf437 |
| institution | Kabale University |
| issn | 1664-2392 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Endocrinology |
| spelling | doaj-art-be60fd8674e44d2eacb73fd63d5cf4372025-01-31T05:10:17ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-01-011610.3389/fendo.2025.15011101501110Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOSPaola Quaresima0Samuel H. Myers1Basilio Pintaudi2Basilio Pintaudi3Rosario D’Anna4Rosario D’Anna5Michele Morelli6Vittorio Unfer7Vittorio Unfer8Department of Obstetrics and Gynecology, Azienda Sanitaria Provinciale di Cosenza, Cosenza, ItalyR&D Department, Lo.Li Pharma s.r.l, Rome, ItalyThe Experts Group on Inositol in Basic and Clinical Research and on PCOS (EGOI-PCOS), Rome, ItalyAzienda Socio Sanitaria Territoriale (ASST) Grande Ospedale Metropolitano Niguarda, Milan, ItalyThe Experts Group on Inositol in Basic and Clinical Research and on PCOS (EGOI-PCOS), Rome, ItalyDepartment of Human Pathology, University of Messina, Messina, ItalyDepartment of Obstetrics and Gynecology, Annunziata Hospital, Cosenza, ItalyThe Experts Group on Inositol in Basic and Clinical Research and on PCOS (EGOI-PCOS), Rome, ItalyUniCamillus-Saint Camillus International University of Health Sciences, Rome, ItalyGestational diabetes mellitus is a worldwide health issue in pregnancy, posing a threat to both mother and child. One of the major risk factors for the development of gestational diabetes mellitus is polycystic ovary syndrome, primarily due to the biochemical hyperandrogenism and metabolic issues, commonly observed in these patients. In recent years, the Expert Group on Inositol in Basic and Clinical Research and on PCOS (EGOI-PCOS) has sought to better understand the pathogenesis behind polycystic ovary syndrome, in order to accurately diagnose and treat patients according to their individual needs. Through the scope of polycystic ovary syndrome, this position paper examines the characteristics of both conditions, and underlying biological mechanisms, before moving on to common treatment strategies to avoid or treat gestational diabetes mellitus in women with polycystic ovary syndrome.https://www.frontiersin.org/articles/10.3389/fendo.2025.1501110/fullgestational diabetes mellituspolycystic ovary syndromeinsulinmetforminmyo-inositol |
| spellingShingle | Paola Quaresima Samuel H. Myers Basilio Pintaudi Basilio Pintaudi Rosario D’Anna Rosario D’Anna Michele Morelli Vittorio Unfer Vittorio Unfer Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS Frontiers in Endocrinology gestational diabetes mellitus polycystic ovary syndrome insulin metformin myo-inositol |
| title | Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS |
| title_full | Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS |
| title_fullStr | Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS |
| title_full_unstemmed | Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS |
| title_short | Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS |
| title_sort | gestational diabetes mellitus and polycystic ovary syndrome a position statement from egoi pcos |
| topic | gestational diabetes mellitus polycystic ovary syndrome insulin metformin myo-inositol |
| url | https://www.frontiersin.org/articles/10.3389/fendo.2025.1501110/full |
| work_keys_str_mv | AT paolaquaresima gestationaldiabetesmellitusandpolycysticovarysyndromeapositionstatementfromegoipcos AT samuelhmyers gestationaldiabetesmellitusandpolycysticovarysyndromeapositionstatementfromegoipcos AT basiliopintaudi gestationaldiabetesmellitusandpolycysticovarysyndromeapositionstatementfromegoipcos AT basiliopintaudi gestationaldiabetesmellitusandpolycysticovarysyndromeapositionstatementfromegoipcos AT rosariodanna gestationaldiabetesmellitusandpolycysticovarysyndromeapositionstatementfromegoipcos AT rosariodanna gestationaldiabetesmellitusandpolycysticovarysyndromeapositionstatementfromegoipcos AT michelemorelli gestationaldiabetesmellitusandpolycysticovarysyndromeapositionstatementfromegoipcos AT vittoriounfer gestationaldiabetesmellitusandpolycysticovarysyndromeapositionstatementfromegoipcos AT vittoriounfer gestationaldiabetesmellitusandpolycysticovarysyndromeapositionstatementfromegoipcos |